Abstract Inflammatory bowel disease (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory disorders of the digestive tract resulting from dysregulated immune responses toward environmental factors in genetically predisposed individuals. This review focus on what is the state of the art of UC pathophysiology, diagnosis, and treatment and how any future findings could drive our clinical practice.
Lopetuso, L. R., Gasbarrini, A., [Ulcerative colitis], <<RECENTI PROGRESSI IN MEDICINA>>, 2016; 107 (6): 297-308-N/A. [doi:10.1701/2296.24690] [http://hdl.handle.net/10807/93888]
[Ulcerative colitis]
Lopetuso, Loris RiccardoPrimo
;Gasbarrini, AntonioUltimo
2016
Abstract
Abstract Inflammatory bowel disease (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory disorders of the digestive tract resulting from dysregulated immune responses toward environmental factors in genetically predisposed individuals. This review focus on what is the state of the art of UC pathophysiology, diagnosis, and treatment and how any future findings could drive our clinical practice.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
